COMMENTARY

A Brief Overview of the Paclitaxel Devices in PAD Controversy

Editor: Tricia Ward; Video Editors: Peter Zunitch; Matt Kalman

Disclosures

June 14, 2019

Disclosures: Lansky reports research grant support from AstraZeneca, Abiomed, Abbott Vascular, Bard, Boston Scientific, Biocardia, Biotronik, Cagent, Cardiatis, Conformal, Gore, Intact Vascular, KeyStone Heart, Venous, Lifetech, Limflow, Medinol, Micell, Microport, Myocardia, Reva, Shockwave Medical, Surmodics, TriReme, Venus, and Veryan Medical. Byrne reports financial relationships with Boston Scientific and Celonova BioSciences. Finn reports research grant support from: Abbott Vascular, Biosensors, Biotronik, Boston Scientific, Concept Medical Research Pvt. Ltd., Edwards Lifesciences, Medtronic, MicroPort, Mitralign, OrbusNeich, Shockwave Medical, Sinomed BV, Medis Medical Imaging Systems BV, and Terumo.

Follow Medscape on Facebook, Twitter, Instagram, and YouTube

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....